Allyson Guidroz - 04 Mar 2025 Form 4 Insider Report for AMEDISYS INC (AMED)

Role: Chief Accounting Officer
Signature: /s/ Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol: AMED
Transactions as of: 04 Mar 2025
Net transactions value: -$187,833
Form type: 4
Filing time: 06 Mar 2025, 16:02:26 UTC
Previous filing: 19 Feb 2025
Next filing: 06 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMED	Common Stock	Sale	$187,833	-2,041	-19%	$92.03	8,761	04 Mar 2025	Direct	F1
holding	AMED	Common Stock						2	04 Mar 2025	By 401(k) Plan	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.9577 to $92.10, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2	The information in this report is based on a plan statement dated as of December 31, 2024.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.9577 to $92.10, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

The information in this report is based on a plan statement dated as of December 31, 2024.